[1] SAKAMOTO J,KAMIURA S,OKAYAMA K,et al.Single type infection of human papillomavirus as a cause for high-grade cervical intraepithelial neoplasia and invasive cancer in Japan[J].Papillomavirus Res,2018,6:46-51.
[2] COHEN PA,BRAND A,SYKES P,et al.Excisional treatment in women with cervical adenocarcinoma in situ (AIS):a prospective randomised controlled non-inferiority trial to compare AIS persistence/recurrence after loop electrosurgical excision procedure with cold knife cone biopsy:protocol for a pilot study[J].BMJ Open,2017,7(8):e017576.
[3] CASTELLSAGU X,DAZ M,DE SANJOS S ,et al.Worldwide human papillomavirus etiology of cervical adenocarcinoma and its cofactors:implications for screening and prevention[J].J Natl Cancer Inst,2006,98(5):303-315.
[4] FINDIK S,ABUOGLU S,CIHAN FG,et al.Human papillomavirus (HPV) subtypes and their relationships with cervical smear results in cervical cancer screening:a community-based study from the central Anatolia region of Turkey[J].Int J Clin Exp Pathol,2019,12(4):1391-1398.
[5] 康红,叶延程,樊平,等.HPV联合TCT检测在宫颈癌筛查中的应用[J].现代肿瘤医学,2020,28(02):283-286.
KANG Hong,YE Yancheng,FAN Ping,et al.The application of HPV combined TCT testing in cervical cancer screening[J].Modern Oncology,2020,28(02):283-286.
[6] SRISOMBOON S,TANTIPALAKORN C,CHAROENKWAN K,et al.Cervical screening results leading to detection of adenocarcinoma in situ of the uterine cervix[J].Asian Pac J Cancer Prev,2019,20(2):377-382.
[7] KURMAN RJ,CARCANGIU ML,HERRINGTON CS,et al.WHO classification of tumours of female reproduction organs[M].4th ed.Lyon:International Agency for Research on Cancer,2014:183-184.
[8] GADDUCCI A,GUERRIERI ME,COSIO S.Adenocarcinoma of the uterine cervix:Pathologic features,treatment options,clinical outcome and prognostic variables[J].Crit Rev Oncol Hematol,2019,135:103-114.
[9] IARC Working Group on the Evaluation of Carcinogenic Risks to Humans.Human papillomaviruses[J].IARC Monogr Eval Carcinog Risks Hum,1995,64:1-378.
[10] 张勤,王冬.高危型HPV感染在宫颈癌前病变、宫颈癌中的临床意义[J].现代肿瘤医学,2020,28(05):788-791.
ZHANG Qin,WANG Dong.Clinical significance of high-risk HPV testing for cervical precancerous lesions and cervical cancer[J].Modern Oncology,2020,28(05):788-791.
[11] 周琴, 钱文艳, 朱艳,等.1081例患者宫颈HR-HPV感染情况分析[J].现代肿瘤医学,2018,26(06):917-919.
ZHOU Qin,QIAN Wenyan,ZHU Yan,et al.The investigation of high-risk human papillomavirus infection in cervix of 1081 women[J].Modern Oncology,2018,26(06):917-919.
[12] SMITH JS,LINDSAY L,HOOT B,et al.Human papillomavirus type distribution in invasive cervical cancer and high-grade cervical lesions:a meta-analysis update[J].Int J Cancer,2007,121(3):621-632.
[13] CODDE E,MUNRO A,STEWART C,et al.Risk of persistent or recurrent cervical neoplasia in patients with 'pure' adenocarcinoma-in-situ (AIS) or mixed AIS and high-grade cervical squamous neoplasia (cervical intra-epithelial neoplasia grades 2 and 3 (CIN 2/3)):a population-based study[J].Bjog,2018,125(1):74-79.
[14] OSTR AG,PAGANO R,DAVOREN RA,et al.Adenocarcinoma in situ of the cervix[J].Int J Gynecol Pathol,1984,3(2):179-190.
[15]贾帅,王晓晶,张欣荣,等.宫颈原位腺癌的临床病理分析[J].诊断病理学杂志,2019,26(2):125-127.
JIA S,WANG XJ,ZHANG XR,et al.Adenocarcinoma in situ of the uterine cervix:a clinicopathological analysis[J].Chinese Journal of Diagnostic Pathology,2019,26(2):125-127.
[16] LAX SF,HORN LC,LNING T.Categorization of uterine cervix tumors:What's new in the 2014 WHO classification[J].Pathologe,2016,37(6):573-584.
[17] KAWAKAMI F,SEMBA S,ITAMI H,et al.Pathogenesis of combined high-grade squamous intraepithelial lesion and adenocarcinoma in situ of the uterine cervix:human papillomavirus genotype and methylation status and immunohistochemical study[J].Kobe J Med Sci,2014,60(3):E66-73.
[18] LEE KR,FLYNN CE.Early invasive adenocarcinoma of the cervix[J].Cancer,2000,89(5):1048-1055.
[19] WHEELER DT,KURMAN RJ.The relationship of glands to thick-wall blood vessels as a marker of invasion in endocervical adenocarcinoma[J].Int J Gynecol Pathol,2005,24(2):125-130.